Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 5101 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 5102 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 5103 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 5104 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Metabolic | 2019 | Standard Therapy | Poland | 3 |
| 5105 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 18 |
| 5106 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 8 |
| 5107 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 10 |
| 5108 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
| 5109 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 30 |
| 5110 | Bone Marrow | Allogeneic | C-Hip Cartilage-Hair Hypoplasia | Orthopedics | 2019 | Standard Therapy | Poland | 2 |
| 5111 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 7 |
| 5112 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 9 |
| 5113 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 35 |
| 5114 | Bone Marrow | Allogeneic | Congenital Amegakaryocytic Thrombocytopenia (Camt) | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 5115 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 5116 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2019 | Standard Therapy | Poland | 6 |
| 5117 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 5118 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 5119 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 5120 | Bone Marrow | Allogeneic | Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 5121 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Metabolic | 2019 | Standard Therapy | Poland | 2 |
| 5122 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
| 5123 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 5124 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5125 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 8 |
| 5126 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 5127 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
| 5128 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 5129 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 27 |
| 5130 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 5131 | Bone Marrow | Allogeneic | Myeloproliferative Syndrome | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 5132 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2019 | Standard Therapy | Poland | 6 |
| 5133 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 5134 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 5135 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 5136 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 5137 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 5138 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 5139 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 5140 | Bone Marrow | Allogeneic | Ohis – Other Histiocytic Disorders | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 5141 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2019 | Standard Therapy | Poland | 1 |
| 5142 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2019 | Standard Therapy | Poland | 5 |
| 5143 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 5144 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 5145 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 22 |
| 5146 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 5147 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 12 |
| 5148 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 5149 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 17 |
| 5150 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
| 5151 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 22 |
| 5152 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 5153 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 5154 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 5155 | Bone Marrow | Allogeneic | Shwachman Diamond Anemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 5156 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 13 |
| 5157 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 5158 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 10 |
| 5159 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 13 |
| 5160 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
| 5161 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 27 |
| 5162 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
| 5163 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 5164 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 5165 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5166 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 18 |
| 5167 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 5168 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
| 5169 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 5170 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 51 |
| 5171 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 7 |
| 5172 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 5173 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 46 |
| 5174 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
| 5175 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5176 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 28 |
| 5177 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
| 5178 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
| 5179 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5180 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 5181 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 32 |
| 5182 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 44 |
| 5183 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5184 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 5185 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 39 |
| 5186 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
| 5187 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 5188 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 5189 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 37 |
| 5190 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
| 5191 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
| 5192 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
| 5193 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 5194 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 38 |
| 5195 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 5196 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 5197 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 5198 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 70 |
| 5199 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 5200 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |